The biotechnology sector is going through the longest “downturn” in its history, while at the same time science is generating revolutionary breakthroughs — from curing genetic diseases to drugs capable of dramatically improving the health of entire nations. Ilya Yasny, Head of Scientific Expertise at LanceBio Ventures, explains how this market works, where real breakthrough technologies are hidden, and how to distinguish them from unfounded hype.

In the Entre Expats podcast, we talk with Monina about what it was like for a young woman with African roots growing up in Catalonia to seek role models outside of Spain, about the courage to go against family expectations, and about how important it is for migrants to give each other visibility and to be heard.

Amid growing risks associated with launching startups, more and more experienced executives are choosing a different path: entrepreneurship through business acquisition. At the Think Wide conference in Barcelona, entrepreneur and investor Elena Trukhina shared her experience with the Search Fund model—an investment mechanism that enables the acquisition of a stable small or medium-sized business with investor backing even before a specific company is selected. This strategy combines managerial autonomy, reduced risk, and high return potential

Nineteen years ago, I tightly connected my life with game development: I became a co-founder of TimeZero. And in 2021, Nexters (of which I am a co-founder) entered NASDAQ with a valuation of around 2 billion dollars.